FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2321946824> ?p ?o ?g. }

• W2321946824 endingPage "29080" @default.
• W2321946824 startingPage "29063" @default.
• W2321946824 abstract "// Gabriel Bidaux 1, 2, 3, * , Anne-Sophie Borowiec 1, 2, * , Charlotte Dubois 1, 2 , Philippe Delcourt 1, 2 , Céline Schulz 1, 2 , Fabien Vanden Abeele 1, 2 , Gilbert Lepage 1, 2 , Emilie Desruelles 1, 2 , Alexandre Bokhobza 1, 2 , Etienne Dewailly 1, 2 , Christian Slomianny 1, 2 , Morad Roudbaraki 1, 2 , Laurent Héliot 3 , Jean-Louis Bonnal 1, 2 , Brigitte Mauroy 1, 2 , Pascal Mariot 1, 2 , Loïc Lemonnier 1, 2 , Natalia Prevarskaya 1, 2 1 Inserm, U-1003, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d’Ascq, France 2 Université des Sciences et Technologies de Lille (USTL), Villeneuve d’Ascq, France 3 Laboratoire de Physique des Lasers, Atomes and Molécules, Equipe Biophotonique Cellulaire Fonctionnelle, Parc Scientifique de la Haute Borne, Villeneuve d’Ascq, France * These authors contributed equally to this work Correspondence to: Gabriel Bidaux, email: gabriel.bidaux@univ-lyon1.fr Keywords: TRPM8, ER calcium fluxes, mitochondria, prostate cancer, apoptosis Received: November 03, 2015      Accepted: March 29, 2016      Published: April 09, 2016 ABSTRACT Since its cloning a decade ago, TRPM8 channel has emerged as a promising prognostic marker and a putative therapeutic target in prostate cancer (PCa). However, recent studies have brought to light the complexity of TRPM8 isoforms in PCa. Consequently, the respective role of each TRPM8 isoform needs to be deciphered prior to considering TRPM8 as an attractive therapeutic target. Full-length (6 transmembrane (TM)-domain) TRPM8 channel is overexpressed in early PCa and repressed in advanced prostate tumors whereas the localization of the truncated, 4TM-TRPM8 channel (4 transmembrane (TM)-domain), in the membranes of endoplasmic reticulum (ER) is independent of the pathogenic status of epithelial cells. In the same line, expression of non-channel cytoplasmic small TRPM8 isoforms (namely sM8) is conserved in cancer cells. In this study, we identify sM8s as putative regulator of PCa cell death. Indeed, suppression of sM8 isoforms was found to induce concomitantly ER stress, oxidative stress, p21 expression and apoptosis in human epithelial prostate cancer cells. We furthermore demonstrate that induction of such mechanisms required the activity of 4TM-TRPM8 channels at the ER-mitochondria junction. Our study thus suggests that targeting sM8 could be an appropriate strategy to fight prostate cancer." @default.
• W2321946824 created "2016-06-24" @default.
• W2321946824 creator A5000634668 @default.
• W2321946824 creator A5007220163 @default.
• W2321946824 creator A5013979737 @default.
• W2321946824 creator A5021423171 @default.
• W2321946824 creator A5024515740 @default.
• W2321946824 creator A5034262933 @default.
• W2321946824 creator A5038200781 @default.
• W2321946824 creator A5045487233 @default.
• W2321946824 creator A5050432911 @default.
• W2321946824 creator A5051373681 @default.
• W2321946824 creator A5051762270 @default.
• W2321946824 creator A5060173638 @default.
• W2321946824 creator A5064083969 @default.
• W2321946824 creator A5070480765 @default.
• W2321946824 creator A5073247738 @default.
• W2321946824 creator A5075904603 @default.
• W2321946824 creator A5078206798 @default.
• W2321946824 creator A5081724012 @default.
• W2321946824 date "2016-04-09" @default.
• W2321946824 modified "2023-10-01" @default.
• W2321946824 title "Targeting of short TRPM8 isoforms induces 4TM-TRPM8-dependent apoptosis in prostate cancer cells" @default.
• W2321946824 cites W1524417563 @default.
• W2321946824 cites W1590223761 @default.
• W2321946824 cites W1623761777 @default.
• W2321946824 cites W1926371918 @default.
• W2321946824 cites W1966467373 @default.
• W2321946824 cites W1979096599 @default.
• W2321946824 cites W1983824549 @default.
• W2321946824 cites W1985997104 @default.
• W2321946824 cites W1986540947 @default.
• W2321946824 cites W1989323482 @default.
• W2321946824 cites W1998249778 @default.
• W2321946824 cites W2002207827 @default.
• W2321946824 cites W2007598683 @default.
• W2321946824 cites W2008756753 @default.
• W2321946824 cites W2008757109 @default.
• W2321946824 cites W2013910899 @default.
• W2321946824 cites W2015946977 @default.
• W2321946824 cites W2021603715 @default.
• W2321946824 cites W2023465240 @default.
• W2321946824 cites W2023691970 @default.
• W2321946824 cites W2024814064 @default.
• W2321946824 cites W2040480790 @default.
• W2321946824 cites W2041736395 @default.
• W2321946824 cites W2044057392 @default.
• W2321946824 cites W2048724765 @default.
• W2321946824 cites W2048831569 @default.
• W2321946824 cites W2050163931 @default.
• W2321946824 cites W2050780119 @default.
• W2321946824 cites W2056295637 @default.
• W2321946824 cites W2058791568 @default.
• W2321946824 cites W2060666913 @default.
• W2321946824 cites W2063085360 @default.
• W2321946824 cites W2072362263 @default.
• W2321946824 cites W2085885479 @default.
• W2321946824 cites W2085933321 @default.
• W2321946824 cites W2086519855 @default.
• W2321946824 cites W2088694013 @default.
• W2321946824 cites W2089531185 @default.
• W2321946824 cites W2117275311 @default.
• W2321946824 cites W2126403388 @default.
• W2321946824 cites W2128932427 @default.
• W2321946824 cites W2133614237 @default.
• W2321946824 cites W2136306650 @default.
• W2321946824 cites W2139077604 @default.
• W2321946824 cites W2139989763 @default.
• W2321946824 cites W2144065885 @default.
• W2321946824 cites W2153535707 @default.
• W2321946824 cites W2165491366 @default.
• W2321946824 cites W2325369788 @default.
• W2321946824 doi "https://doi.org/10.18632/oncotarget.8666" @default.
• W2321946824 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5045378" @default.
• W2321946824 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27074561" @default.
• W2321946824 hasPublicationYear "2016" @default.
• W2321946824 type Work @default.
• W2321946824 sameAs 2321946824 @default.
• W2321946824 citedByCount "28" @default.
• W2321946824 countsByYear W23219468242017 @default.
• W2321946824 countsByYear W23219468242018 @default.
• W2321946824 countsByYear W23219468242019 @default.
• W2321946824 countsByYear W23219468242020 @default.
• W2321946824 countsByYear W23219468242021 @default.
• W2321946824 countsByYear W23219468242022 @default.
• W2321946824 countsByYear W23219468242023 @default.
• W2321946824 crossrefType "journal-article" @default.
• W2321946824 hasAuthorship W2321946824A5000634668 @default.
• W2321946824 hasAuthorship W2321946824A5007220163 @default.
• W2321946824 hasAuthorship W2321946824A5013979737 @default.
• W2321946824 hasAuthorship W2321946824A5021423171 @default.
• W2321946824 hasAuthorship W2321946824A5024515740 @default.
• W2321946824 hasAuthorship W2321946824A5034262933 @default.
• W2321946824 hasAuthorship W2321946824A5038200781 @default.
• W2321946824 hasAuthorship W2321946824A5045487233 @default.
• W2321946824 hasAuthorship W2321946824A5050432911 @default.
• W2321946824 hasAuthorship W2321946824A5051373681 @default.
• W2321946824 hasAuthorship W2321946824A5051762270 @default.

• next